Difference between revisions of "Team:UCC Ireland"

 
(32 intermediate revisions by 2 users not shown)
Line 1: Line 1:
  
−
<html lang="en">
+
 
 +
<html lang="en" xmlns="http://www.w3.org/1999/html">
 
   <head>
 
   <head>
 
     <meta charset="utf-8">
 
     <meta charset="utf-8">
Line 7: Line 8:
 
     <!-- The above 3 meta tags *must* come first in the head; any other head content must come *after* these tags -->
 
     <!-- The above 3 meta tags *must* come first in the head; any other head content must come *after* these tags -->
  
−
     <title>Starter Template for Bootstrap</title>
+
     <title>UCC iGEM</title>
 +
 
 +
    <!-- Bootstrap core CSS -->
 +
    <link rel="stylesheet" href="https://2016.igem.org/Template:Team:UCC_Ireland/CSS?action=raw&amp;ctype=text/css">
  
−
     <link rel="stylesheet" href="{{Team:UCC_Ireland/CSS}}"/>
+
     <script src="https://2016.igem.org/Template:Team:UCC_Ireland/JS?action=raw&amp;ctype=text/javascript"></script>
 
      
 
      
 
   </head>
 
   </head>
Line 24: Line 28:
 
               <span class="icon-bar"></span>
 
               <span class="icon-bar"></span>
 
             </button>
 
             </button>
−
            <a class="navbar-brand" href="#"><img style="height: 64px;" src="img/Seema - Final.png" alt=""></a>
+
              <a class="navbar-brand" href="https://2016.igem.org/Team:UCC_Ireland"><img style="height: 80px;" src="https://static.igem.org/mediawiki/2016/a/a3/LIMITLESSLACTIS-WHITE.png" alt=""></a>
 
           </div>
 
           </div>
 
           <div id="navbar" class="navbar-collapse collapse">
 
           <div id="navbar" class="navbar-collapse collapse">
 
             <ul class="nav navbar-nav">
 
             <ul class="nav navbar-nav">
−
               <li class="active"><a href="#">Home</a></li>
+
               <li class="active"><a href="https://2016.igem.org/Team:UCC_Ireland">Home</a></li>
−
               <li><a href="project.html">Project</a></li>
+
               <li class="dropdown">
−
              <li><a href="outreach.html">Outreach</a></li>
+
                <a class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Project<span class="caret"></span></a>
−
               <li><a href="team.html">Team</a></li>
+
                <ul class="dropdown-menu">
−
               <li><a href="notebook.html">Notes</a></li>
+
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Limitless_Lactis">Limitless Lactis</a></li>
−
               <li><a href="parts.html">Parts</a></li>
+
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/iRFP">iRFP In-Vitro Reporter</a></li>
−
               <li><a href="collaborations.html">Collaborations</a></li>
+
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Leishmaniasis">Leishmaniasis</a></li>
−
               <li><a href="interlab_study">Interlab</a></li>
+
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Proof">Proof</a></li>
−
               <li><a href="achievements.html">Achievements</a></li>
+
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Demonstrate">Demonstrate</a></li>
−
               <li><a href="attributions.html">Attributions</a></li>
+
                </ul>
 +
              </li>
 +
              <li class="dropdown">
 +
                <a class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Outreach<span class="caret"></span></a>
 +
                <ul class="dropdown-menu">
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/HP/Silver">HP Silver</a></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/HP/Gold">HP Gold</a></li>
 +
                  <li role="separator" class="divider"></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Engagement">Engagement</a></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Integrated_Practices">Integrated Practices</a></li>
 +
                </ul>
 +
              </li>
 +
               <li><a href="https://2016.igem.org/Team:UCC_Ireland/Team">Team</a></li>
 +
               <li><a href="https://2016.igem.org/Team:UCC_Ireland/Notebook">Notes</a></li>
 +
               <li><a href="https://2016.igem.org/Team:UCC_Ireland/Parts">Parts</a></li>
 +
               <li class="dropdown">
 +
                <a class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Collaborations<span class="caret"></span></a>
 +
                <ul class="dropdown-menu">
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Collaborations">iGEM Teams</a></li>
 +
                  <li role="separator" class="divider"></li>
 +
                  <li class="dropdown-header">Synenergene</li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Application_Scenario">Application Scenario</a></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Techno_Moral_Newsletter">Techno-Moral Newsletter</a></li>
 +
                  <li><a href="https://2016.igem.org/Team:UCC_Ireland/Blog.html">Techno-Moral Blog</a></li>
 +
                </ul>
 +
              </li>
 +
               <li><a href="https://2016.igem.org/Team:UCC_Ireland/Interlab_Study">Interlab</a></li>
 +
               <li><a href="https://2016.igem.org/Team:UCC_Ireland/Achievements">Achievements</a></li>
 +
               <li><a href="https://2016.igem.org/Team:UCC_Ireland/Attributions">Attributions</a></li>
 
             </ul>
 
             </ul>
 
           </div>
 
           </div>
 
         </div>
 
         </div>
 
       </nav>
 
       </nav>
−
       <div class="container-fluid" id="home">
+
       <div class="container-fluid fix-nav-padding-top">
  
 
         <div class="row" id="landing">
 
         <div class="row" id="landing">
 
           <div class="col-xs-12 col-md-12">
 
           <div class="col-xs-12 col-md-12">
−
             <h1 class="text-uppercase text-center">Limitless Lactis</h1>
+
 
−
            <p class="lead text-center">Intelligent <em>Lactococcus lactis</em> strains as a protein delivery platform for disease treatment.</p>
+
             <img style="width: 400px; display:block; margin:auto;" src="https://static.igem.org/mediawiki/2016/6/6b/T--UCC_Ireland--LIMITLESSLACTIS-BLACK.png" alt="">
 
              
 
              
−
            <img style="width: 230px; display:block; margin:auto;" src="img/Seema - Final.png" alt="">
 
−
            <p class="lead text-center" style="padding: 10px;">
 
−
              <a class="btn btn-primary btn-lg" href="#" role="button">Learn more</a>
 
−
            </p>
 
 
           </div>
 
           </div>
 
         </div><!-- /landing -->
 
         </div><!-- /landing -->
−
         <div class="col-md-12 social-badge">
+
          
−
          <a href="#abstract">
+
−
          <span class="fa fa-arrow-circle-down fa-5x"></span></a>
+
−
        </div>
+
  
 
         <div class="row text-center" id="abstract">
 
         <div class="row text-center" id="abstract">
 
           <div class="col-xs-12 col-md-8 col-md-offset-2">
 
           <div class="col-xs-12 col-md-8 col-md-offset-2">
−
             <h2 class="text-uppercase">Abstract</h2>
+
             <h2 class="text-center"><span>Limitless Lactis:</span> Intelligent <em>Lactococcus lactis</em> strains as a protein delivery platform for disease treatment.</h2>
−
            <p class="lead text-left">
+
    <hr>
−
               <em>Lactococcus lactis</em>, a generally recognised as safe (GRAS) bacterium commonly used in food production, is highly amenable to genetic manipulation. We aim to develop a synthetic L. lactis-based platform that can deliver proteins to immune cells to precisely influence the host immune response for use in the treatment of various diseases. Potential applications which we have investigated include vaccination strategies and macrophage modification. We have developed the platform as a vaccine against leishmaniasis, a neglected tropical disease increasing in geographical distribution. LJM11 is an immunogenic salivary protein of the sandfly vector, Lutzomyia longipalpis. Our inexpensive platform, through simple oral administration, has the capacity to deliver this protein to antigen-presenting cells, and potentially immunise against the life cycle of leishmaniasis. Besides vaccination strategies, this platform may be employed to modify the phenotype of other phagocytic cells associated with diseases such as cancer.
+
              <p class="lead text-left">
 +
               <em>Lactococcus lactis</em>, a generally recognised as safe (GRAS) bacterium commonly used in food production, is highly amenable to genetic manipulation. We aim to develop a synthetic <em>L. lactis</em>-based platform that can deliver proteins to immune cells to precisely influence the host immune response for use in the treatment of various diseases. Potential applications which we have investigated include vaccination strategies and macrophage modification. We have developed the platform as a vaccine against leishmaniasis, a neglected tropical disease increasing in geographical distribution. LJM11 is an immunogenic salivary protein of the sandfly vector, <em>Lutzomyia longipalpis</em>. Our inexpensive platform, through simple oral administration, has the capacity to deliver this protein to antigen-presenting cells, and potentially immunise against the life cycle of leishmaniasis. Besides vaccination strategies, this platform may be employed to modify the phenotype of other phagocytic cells associated with diseases such as cancer.
 
             </p>
 
             </p>
 +
              <hr>
 +
              <div align="center" class="embed-responsive embed-responsive-16by9">
 +
                <video controls class="embed-responsive-item">
 +
                  <source src="https://static.igem.org/mediawiki/2016/e/e3/T--UCC_Ireland--I-Like-It-Lactis-UCC-iGEM-2016-SONG.mp4" type="video/mp4">
 +
                </video>
 +
              </div>
 
           </div>
 
           </div>
 
         </div><!-- /abstract -->
 
         </div><!-- /abstract -->
Line 75: Line 107:
  
 
         <div class="row" id="sponsors">
 
         <div class="row" id="sponsors">
−
           <div class="col-xs-12 col-md-12 text-center text-uppercase">
+
           <div class="col-xs-12 col-md-11 col-md-11 text-center text-uppercase">
 
             <div class="row">
 
             <div class="row">
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/ccrclogoeditkev.png" alt="">
+
    <a href="http://apc.ucc.ie/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/f/f3/T--UCC_Ireland--apc.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/COMH.jpg" alt="">
+
    <a href="http://www.ccrc.ie/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/a/a6/T--UCC_Ireland--ccrc.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/Fyffes_SVG_logo.svg.png" alt="">
+
    <a href="https://www.ucc.ie/en/med-health/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/2/20/T--UCC_Ireland--COMH.jpg" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/genscripteditkevin.png" alt="">
+
    <a href="http://www.fyffes.us/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/f/f8/T--UCC_Ireland--Fyffes_SVG_logo.svg.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/IDT_logo_trans.png" alt="">
+
    <a href="http://www.genscript.com/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/5/5b/T--UCC_Ireland--genscripteditkevin.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/logo (1).png" alt="">
+
    <a href="http://www.lilly.ie/en/index.aspx" target="_blank"><img src="https://static.igem.org/mediawiki/2016/7/73/T--UCC_Ireland--hutchinsonlilly-2vd3ujlywuaxuzb5zmonpc.jpg" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/ccrclogoeditkev.png" alt="">
+
    <a href="http://eu.idtdna.com/site" target="_blank"><img src="https://static.igem.org/mediawiki/2016/b/b0/T--UCC_Ireland--IDT_logo_trans.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/COMH.jpg" alt="">
+
    <a href="http://www.janssen.com/ireland/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/6/65/T--UCC_Ireland--Janssen.jpg" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/Fyffes_SVG_logo.svg.png" alt="">
+
    <a href="https://www.synenergene.eu/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/e/ef/T--UCC_Ireland--logo%281%29.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/genscripteditkevin.png" alt="">
+
    <a href="https://www.ucc.ie/en/biochemistry/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/0/03/T--UCC_Ireland--schoolofbiochemlogoeditkevin.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
  <div class="col-xs-4 col-md-1 col-lg-1">
−
                <img src="img/IDT_logo_trans.png" alt="">
+
    <a href="http://www.ucc.ie/en/" target="_blank"><img src="https://static.igem.org/mediawiki/2016/4/47/T--UCC_Ireland--ucc.png" alt=""></a>
−
              </div>
+
  </div>
−
              <div class="col-xs-2 col-md-1">
+
</div>
−
                <img src="img/logo (1).png" alt="">
+
             <br>
−
              </div>
+
            <br>
−
             </div>
+
            <br>
 +
            <br>
 +
          </div>
 +
        </div><!-- /sponsors -->
 
             <br>
 
             <br>
 
             <br>
 
             <br>
Line 126: Line 161:
 
     </div> <!-- /container full -->
 
     </div> <!-- /container full -->
  
−
 
−
 
−
    <!-- Bootstrap core JavaScript
 
−
    ================================================== -->
 
−
    <!-- Placed at the end of the document so the pages load faster -->
 
−
    <script src="js/jquery.js"></script>
 
−
    <script>window.jQuery || document.write('<script src="js/jquery.js"><\/script>')</script>
 
−
    <script src="js/bootstrap.js"></script>
 
 
   </body>
 
   </body>
 
</html>
 
</html>

Latest revision as of 00:07, 20 October 2016


UCC iGEM

Limitless Lactis: Intelligent Lactococcus lactis strains as a protein delivery platform for disease treatment.

Lactococcus lactis, a generally recognised as safe (GRAS) bacterium commonly used in food production, is highly amenable to genetic manipulation. We aim to develop a synthetic L. lactis-based platform that can deliver proteins to immune cells to precisely influence the host immune response for use in the treatment of various diseases. Potential applications which we have investigated include vaccination strategies and macrophage modification. We have developed the platform as a vaccine against leishmaniasis, a neglected tropical disease increasing in geographical distribution. LJM11 is an immunogenic salivary protein of the sandfly vector, Lutzomyia longipalpis. Our inexpensive platform, through simple oral administration, has the capacity to deliver this protein to antigen-presenting cells, and potentially immunise against the life cycle of leishmaniasis. Besides vaccination strategies, this platform may be employed to modify the phenotype of other phagocytic cells associated with diseases such as cancer.